The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization

The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization

Aim. Determination of the prognostic value of 1.5-anhydroglucitol (1.5-AG) for the development of cardiovascular events in patients with coronary heart disease (CHD) within a year after a planned percutaneous coronary intervention (PCI). Materials and methods. A prospective study was conducted in Fe...

Full description

Bibliographic Details
Main Authors: Yu S Ignatova, V N Karetnikova, A A Horlampenko, O V Gruzdeva, Yu A Dyleva, O L Barbarash
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2019-04-01
Series:Терапевтический архив
Subjects:
coronary heart disease
1,5-anhydroglucitol
percutaneous coronary intervention
prognosis
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/33590/pdf

Similar Items

Similar Items